Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2005
The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetineGerard J Marek, Raul Martin-Ruiz, Allyson Abo, et al.
The International Journal of Neuropsychopharmacology|December 1, 2005
Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamineMercè Amargós-Bosch, Xavier López-Gil, Francesc Artigas, et al.
Biological Psychiatry|April 26, 2008
The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugsPau Celada, M Victoria Puig, Llorenç Díaz-Mataix, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 30, 2004
Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortexNoemí Santana, Analía Bortolozzi, Jordi Serrats, et al.
Neurotoxicity Research|December 17, 2008
NMDA antagonist and antipsychotic actions in cortico-subcortical circuitsLucila Kargieman, Noemí Santana, Guadalupe Mengod, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2014
Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic miceRaquel Gomez-Sintes, Analia Bortolozzi, Francesc Artigas, et al.
The International Journal of Neuropsychopharmacology|July 20, 2011
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorderEnric Alvarez, Victor Perez, Marianne Dragheim, et al.
Neuropharmacology|June 2, 2012
Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategiesMercè Masana, Anna Castañé, Noemí Santana, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2007
Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidineLucila Kargieman, Noemí Santana, Guadalupe Mengod, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2015
5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetineAnna Castañé, Lucila Kargieman, Pau Celada, et al.
Pageof 12